The Effect of Vitamin C on Wound Healing In Mandibular Fracture Patients

NCT03938584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2022-01-26

No results posted yet for this study

Summary

The goal of this study is to perform a randomized clinical trial to assess the effects of vitamin C versus placebo on wound healing in mandibular fracture patients.

Conditions

  • Vitamin C Deficiency
  • Smoking
  • Surgery
  • Surgery--Complications
  • Wound
  • Wound Complication
  • Wound Infection
  • Wound Dehiscence
  • Wound of Skin
  • Mandible Fracture
  • Mandible Open Fracture
  • Mandible Closed Fracture
  • Mandibular Fractures
  • Ascorbic Acid Deficiency
  • Oxidative Stress
  • Inflammation

Interventions

DIETARY_SUPPLEMENT

Vitamin C

Just after induction of anesthesia in the OR, subjects will be administered a single intravenous (IV) dose of Vitamin C at 66mg/kg/hr for 2 hours during surgery. Post-operatively (beginning the morning after surgery) Vitamin C Treatment Group subjects will receive a 4 week prescription of oral, liquid Vitamin C, 500mg by mouth two times a day. These dosages are known to be safe and effective.89-91

OTHER

Placebo

Subjects will receive IV placebo (normal saline) identically packaged. Post-operatively Placebo Control Treatment Group participants will receive a 4-week prescription of the aqueous solution base used for the treatment group without the active component (Vitamin C).

Sponsors & Collaborators

  • Regions Hospital

    collaborator OTHER
  • University of Minnesota

    collaborator OTHER
  • Hennepin Healthcare Research Institute

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2021-06-01
Completion
2021-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03938584 on ClinicalTrials.gov